All expert- and evidence-based resources developed within the ASK Biosimilars Real-World Evidence (RWE) programme are now available to view and download on the ASK Biosimilars website.
This programme shares the latest data surrounding successful implementation of oncology biosimilars through an abstract library of key published paper summaries and a case study series discussing benefits of biosimilar adoption in different healthcare systems.
Developed with global expert oncology pharmacists, these resources were designed with the oncology multidisciplinary team (MDT) at the forefront. The new ‘education hub’ hosts 5 impactful regional case studies reflecting on biosimilar adoption in Australia, Canada, Italy, the UK, and the USA. It also shares a global overview of the recurring themes concerning biosimilar uptake success and acceptance that emerged. The case studies can be downloaded individually or as a full compendium to cascade further throughout the oncology MDT.
The global case study was developed with Jatinder Harchowal MBE (Chief Pharmacist at University College London Hospitals NHS Foundation Trust), who emphasises the value of considering RWE for advancing healthcare practice. The abstracts are compiled into three strategic areas – switching, implementation and economics and can be downloaded as each topic or a complete library.
Marketed to our oncology MDT community (oncologists, hospital pharmacists, secondary care nurses, advanced practice providers, and payors) via Cogora key media brands, faculty networks and worldwide societies, PCM Scientific is thrilled with the uptake.
The awareness campaign has led to fantastic engagement with over 13,000 pageviews of the resources within the first 3-month period. Explore the programme and educational resources on the ASK Biosimilars website.